Your Article Summary
See Latest ArticlesPathogenesis of adrenocortical cancer
Best Practice & Research Clinical Endocrinology & Metabolism, 06/19/09
Bertherat J et al. – Review summarizes the advances in understanding the molecular mechanisms underlying adrenocortical tumour (ACT) development that have been made in the last decade and came from studies of rare familial diseases predisposing to adrenocortical cancer (ACC) and from gene profiling studies of ACT. Review concludes that:
- The role of genetic alterations seems central in the development of ACC.
- Some molecular alterations, such as 17p13 LOH or 11p15 UPD (unipaternal disomy), are common in ACC and might occur early in tumour development.
- Other events, such as TP53 somatic mutations, might be restricted to a subset of aggressive ACCs.
- Considering the major differences in the transcriptome of benign and malignant tumours, it is plausible that ACC and benign adenomas arise from different mechanisms.
- Development of new molecular tools for the assessment of the prognosis of adrenocortical cancer.
- Identification of genes involved in the main chromosomal alterations of adrenocortical cancer (i.e. 17p13, 11q13…)
- Development of therapy targeting the major signalling pathways activated in adrenocortical cancer (i.e. IGF-II, Wnt/β-catenin…)
Today in Adrenal Glands...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Pituitary, 12/08/09
The Utility of Metaiodobenzylguanidine Single Photon Emission Computed Tomography/Computed Tomography (MIBG SPECT/CT) for the Diagnosis of Pheochromocytoma
Annals of Surgical Oncology, 12/08/09
A Case of Human Intramuscular Adrenal Gland Transplantation as a Cure for Chronic Adrenal Insufficiency
American Journal of Transplantation, 12/08/09
Today in Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
European Journal of Nuclear Medicine & Molecular Imaging, 12/08/09
The Utility of Metaiodobenzylguanidine Single Photon Emission Computed Tomography/Computed Tomography (MIBG SPECT/CT) for the Diagnosis of Pheochromocytoma
Annals of Surgical Oncology, 12/08/09
Minimally invasive and conventional glucose monitoring did not differ for long-term glycaemic control in insulin-treated diabetes
Evidence-Based Medicine, 12/07/09
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Re-Evaluation of Histopathological Factors Affecting Prognosis of Differentiated Thyroid Carcinoma in an Iodine-Sufficient Country
World Journal of Surgery, 12/10/09
Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC–FFCD 9710
Endocrine-Related Cancer, 12/09/09
Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer
Endocrine-Related Cancer, 12/09/09